Lymphocyte-Rich Classical Hodgkin Lymphoma
2 clinical trials · Condition
◉ Watch Lymphocyte-Rich Classical Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma (NCT03226249) | Northwestern University | 2017-11-09 |
| Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma (NCT03077828) | Northwestern University | 2017-04-21 |
Track Lymphocyte-Rich Classical Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.